Rostaing L - Search Results

1

Switching from calcineurin inhibitor-based regimens to a belatacept-based regimen in renal transplant recipients: a randomized phase II study.

Rostaing L, Massari P, Garcia VD, Mancilla-Urrea E, Nainan G, del Carmen Rial M, Steinberg S, Vincenti F, Shi R, Di Russo G, Thomas D, Grinyó J. Rostaing L, et al. Clin J Am Soc Nephrol. 2011 Feb;6(2):430-9. doi: 10.2215/CJN.05840710. Epub 2010 Nov 4. Clin J Am Soc Nephrol. 2011. PMID: 21051752 Free PMC article. Clinical Trial.

2

Renal functional reserve in cyclosporin-treated recipients of kidney transplant.

Ader JL, Tack I, Lloveras JJ, Tran-Van T, Rostaing L, Praddaude F, Durand D, Suc JM. Ader JL, et al. Among authors: rostaing l. Kidney Int. 1994 Jun;45(6):1657-67. doi: 10.1038/ki.1994.217. Kidney Int. 1994. PMID: 7933813 Free article.

3

Long-term follow-up of monoclonal gammopathy of undetermined significance in transplant patients.

Rostaing L, Modesto A, Abbal M, Durand D. Rostaing L, et al. Am J Nephrol. 1994;14(3):187-91. doi: 10.1159/000168712. Am J Nephrol. 1994. PMID: 7977478

4

Renal functional reserve in calcium channel blocker-treated hypertensive recipients of kidney transplant.

Tack I, Rostaing L, Tran-Van T, Lloveras JJ, Durand D, Suc JM, Ader JL. Tack I, et al. Among authors: rostaing l. Nephrol Dial Transplant. 1995;10 Suppl 6:117-9. doi: 10.1093/ndt/10.supp6.117. Nephrol Dial Transplant. 1995. PMID: 8524480 Clinical Trial.

5

Renal functional reserve in kidney and heart transplant recipients.

Ader JL, Tack I, Durand D, Tran-Van T, Rostaing L, Suc JM. Ader JL, et al. Among authors: rostaing l. J Am Soc Nephrol. 1996 Aug;7(8):1145-52. doi: 10.1681/ASN.V781145. J Am Soc Nephrol. 1996. PMID: 8866405

6

Serological markers of autoimmunity in renal transplant patients before and after alpha-interferon therapy for chronic hepatitis C.

Rostaing L, Oksman F, Izopet J, Baron E, Cisterne JM, Hoff M, Abbal M, Durand D. Rostaing L, et al. Am J Nephrol. 1996;16(6):478-83. doi: 10.1159/000169047. Am J Nephrol. 1996. PMID: 8955758

7

Treatment of chronic hepatitis B and C with alpha interferon in a renal transplant patient.

Rostaing L, Izopet J, Cisterne JM, Baron E, Rumeau JL, Chabannier MH, Duffaut M, Durand D. Rostaing L, et al. Scand J Urol Nephrol. 1996 Dec;30(6):485-7. doi: 10.3109/00365599609182328. Scand J Urol Nephrol. 1996. PMID: 9008030

8

Prevalence of antibodies to hepatitis C virus and correlation with liver disease in renal transplant patients.

Rostaing L, Izopet J, Cisterne JM, Icart J, Chabannier MH, Panicali H, Durand D. Rostaing L, et al. Am J Nephrol. 1997;17(1):46-52. doi: 10.1159/000169071. Am J Nephrol. 1997. PMID: 9057953

9

Changes in blood pressure and renal function following subtotal parathyroidectomy in renal transplant patients presenting with persistent hypercalcemic hyperparathyroidism.

Rostaing L, Moreau-Gaudry X, Baron E, Cisterne JM, Monroziès-Bernadet P, Durand D. Rostaing L, et al. Clin Nephrol. 1997 Apr;47(4):248-55. Clin Nephrol. 1997. PMID: 9128792

10

Kinetics of HCV viremia in kidney transplant recipients during and after alpha-interferon therapy.

Izopet J, Rostaing L, Ton-That H, Dubois M, Cazabat M, Charlet JP, Sayada C, Duffaut M, Durand D, Puel J. Izopet J, et al. Among authors: rostaing l. Am J Nephrol. 1997;17(5):417-20. doi: 10.1159/000169133. Am J Nephrol. 1997. PMID: 9382158

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

658 results

Search Page

Filters